Author:
Maida Shohei,Nakagawa Hiromi,Ureshino Hiroshi,Kajihara Kyoko,Yamazaki Shinichi,Ichinohe Tatsuo
Reference18 articles.
1. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status;Kawabata;J. Clin. Exp. Hematop.,2013
2. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?;Fujimoto;Am. J. Hematol.,2019
3. TAFRO syndrome: a disease requiring immediate medical attention;Masaki;Intern. Med.,2023
4. Overview of castleman disease;Dispenzieri;Blood,2020
5. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease;Nishimura;Am. J. Hematol.,2021